Work

P109 Efficacy outcomes by baseline prostate-specific antigen (PSA): Results from the Phase III AFFIRM trial

Year: 2013

Type: conference-abstract

Source: European Urology Supplements

DOI: 10.1016/s1569-9056(13)62434-3

Authors: Y. Loriot, F. Saad, J.S. De Bono, N.D. Shore, K. Fizazi, M. Hirmand, D. Forer, H.I. Scher

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2093389110

Cites:

Cited by: 2

Related to: 10